FGF23 and inflammation

por Sharaf El Din, Usama A A, Salem, Mona M, Abdulazim, Dina O
Publicado 2017

Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review

por Sharaf El Din, Usama A.A., Salem, Mona M., Abdulazim, Dina O.
Publicado 2017

Diabetic nephropathy: Time to withhold development and progression - A review

por Sharaf El Din, Usama A.A., Salem, Mona M., Abdulazim, Dina O.
Publicado 2017

Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review

por Sharaf El Din, Usama A.A., Salem, Mona M., Abdulazim, Dina O.
Publicado 2017

The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers

por NasrAllah, Mohamed M., El-Shehaby, Amal R., Osman, Noha A., Fayad, Tarek, Nassef, Amr, Salem, Mona M., Sharaf El Din, Usama A.A.
Publicado 2013